EP2167021A1 - Dentrifice composition - Google Patents
Dentrifice compositionInfo
- Publication number
- EP2167021A1 EP2167021A1 EP08774508A EP08774508A EP2167021A1 EP 2167021 A1 EP2167021 A1 EP 2167021A1 EP 08774508 A EP08774508 A EP 08774508A EP 08774508 A EP08774508 A EP 08774508A EP 2167021 A1 EP2167021 A1 EP 2167021A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- weight
- composition
- zinc
- dentifrice
- dentifrice composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 104
- 239000000551 dentifrice Substances 0.000 claims abstract description 52
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims abstract description 23
- 239000003906 humectant Substances 0.000 claims abstract description 18
- 150000003751 zinc Chemical class 0.000 claims description 34
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 11
- 239000000600 sorbitol Substances 0.000 claims description 11
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 claims description 10
- 239000011686 zinc sulphate Substances 0.000 claims description 10
- 235000009529 zinc sulphate Nutrition 0.000 claims description 10
- 235000011187 glycerol Nutrition 0.000 claims description 9
- 239000000796 flavoring agent Substances 0.000 claims description 8
- 235000019634 flavors Nutrition 0.000 claims description 8
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical group [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 claims description 6
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 claims description 4
- 239000011746 zinc citrate Substances 0.000 claims description 4
- 235000006076 zinc citrate Nutrition 0.000 claims description 4
- 229940068475 zinc citrate Drugs 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 239000011592 zinc chloride Substances 0.000 claims description 3
- 235000005074 zinc chloride Nutrition 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000001680 brushing effect Effects 0.000 description 25
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 20
- 235000019606 astringent taste Nutrition 0.000 description 16
- 239000000499 gel Substances 0.000 description 10
- 239000000377 silicon dioxide Substances 0.000 description 10
- 210000000214 mouth Anatomy 0.000 description 9
- 239000003795 chemical substances by application Substances 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 8
- 229960005150 glycerol Drugs 0.000 description 8
- 239000004615 ingredient Substances 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 230000007937 eating Effects 0.000 description 7
- 239000000606 toothpaste Substances 0.000 description 7
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 6
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 6
- -1 citrate Chemical class 0.000 description 6
- 235000003599 food sweetener Nutrition 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 6
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 6
- 229940068196 placebo Drugs 0.000 description 6
- 239000000902 placebo Substances 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 6
- 239000004094 surface-active agent Substances 0.000 description 6
- 239000003765 sweetening agent Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 150000003573 thiols Chemical class 0.000 description 6
- 235000010447 xylitol Nutrition 0.000 description 6
- 239000000811 xylitol Substances 0.000 description 6
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 6
- 229960002675 xylitol Drugs 0.000 description 6
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical class [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 5
- 239000004705 High-molecular-weight polyethylene Substances 0.000 description 5
- 239000003082 abrasive agent Substances 0.000 description 5
- 230000035622 drinking Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000012071 phase Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 229940034610 toothpaste Drugs 0.000 description 5
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 4
- 229940091249 fluoride supplement Drugs 0.000 description 4
- 239000007791 liquid phase Substances 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 210000003296 saliva Anatomy 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 208000006558 Dental Calculus Diseases 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 229910000323 aluminium silicate Inorganic materials 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 125000000129 anionic group Chemical group 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 235000010216 calcium carbonate Nutrition 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000000391 smoking effect Effects 0.000 description 3
- 239000011775 sodium fluoride Substances 0.000 description 3
- 235000013024 sodium fluoride Nutrition 0.000 description 3
- 235000019640 taste Nutrition 0.000 description 3
- 239000002562 thickening agent Substances 0.000 description 3
- 239000004408 titanium dioxide Substances 0.000 description 3
- 239000005995 Aluminium silicate Substances 0.000 description 2
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 2
- 235000005979 Citrus limon Nutrition 0.000 description 2
- 244000131522 Citrus pyriformis Species 0.000 description 2
- VUNOFAIHSALQQH-UHFFFAOYSA-N Ethyl menthane carboxamide Chemical compound CCNC(=O)C1CC(C)CCC1C(C)C VUNOFAIHSALQQH-UHFFFAOYSA-N 0.000 description 2
- 244000024873 Mentha crispa Species 0.000 description 2
- 235000014749 Mentha crispa Nutrition 0.000 description 2
- 244000246386 Mentha pulegium Species 0.000 description 2
- 235000016257 Mentha pulegium Nutrition 0.000 description 2
- 235000004357 Mentha x piperita Nutrition 0.000 description 2
- 235000011203 Origanum Nutrition 0.000 description 2
- 240000000783 Origanum majorana Species 0.000 description 2
- 238000000692 Student's t-test Methods 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 2
- CANRESZKMUPMAE-UHFFFAOYSA-L Zinc lactate Chemical compound [Zn+2].CC(O)C([O-])=O.CC(O)C([O-])=O CANRESZKMUPMAE-UHFFFAOYSA-L 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- 235000012211 aluminium silicate Nutrition 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- 230000000675 anti-caries Effects 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 229940112822 chewing gum Drugs 0.000 description 2
- 235000015218 chewing gum Nutrition 0.000 description 2
- 235000017803 cinnamon Nutrition 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 239000002826 coolant Substances 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- MFGZXPGKKJMZIY-UHFFFAOYSA-N ethyl 5-amino-1-(4-sulfamoylphenyl)pyrazole-4-carboxylate Chemical compound NC1=C(C(=O)OCC)C=NN1C1=CC=C(S(N)(=O)=O)C=C1 MFGZXPGKKJMZIY-UHFFFAOYSA-N 0.000 description 2
- CBOQJANXLMLOSS-UHFFFAOYSA-N ethyl vanillin Chemical group CCOC1=CC(C=O)=CC=C1O CBOQJANXLMLOSS-UHFFFAOYSA-N 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 235000001050 hortel pimenta Nutrition 0.000 description 2
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 2
- 229960001047 methyl salicylate Drugs 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- CFJYNSNXFXLKNS-UHFFFAOYSA-N p-menthane Chemical compound CC(C)C1CCC(C)CC1 CFJYNSNXFXLKNS-UHFFFAOYSA-N 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 238000005498 polishing Methods 0.000 description 2
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 235000002020 sage Nutrition 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 235000021259 spicy food Nutrition 0.000 description 2
- ANOBYBYXJXCGBS-UHFFFAOYSA-L stannous fluoride Chemical compound F[Sn]F ANOBYBYXJXCGBS-UHFFFAOYSA-L 0.000 description 2
- 229960002799 stannous fluoride Drugs 0.000 description 2
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 2
- 239000003981 vehicle Substances 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000011670 zinc gluconate Substances 0.000 description 2
- 235000011478 zinc gluconate Nutrition 0.000 description 2
- 229960000306 zinc gluconate Drugs 0.000 description 2
- 239000011576 zinc lactate Substances 0.000 description 2
- 235000000193 zinc lactate Nutrition 0.000 description 2
- 229940050168 zinc lactate Drugs 0.000 description 2
- ONDPHDOFVYQSGI-UHFFFAOYSA-N zinc nitrate Chemical compound [Zn+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ONDPHDOFVYQSGI-UHFFFAOYSA-N 0.000 description 2
- 239000002888 zwitterionic surfactant Substances 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- NFLGAXVYCFJBMK-RKDXNWHRSA-N (+)-isomenthone Natural products CC(C)[C@H]1CC[C@@H](C)CC1=O NFLGAXVYCFJBMK-RKDXNWHRSA-N 0.000 description 1
- PXLKJWMSFPYVNB-UHFFFAOYSA-N (1-methyl-4-propan-2-ylcyclohexyl) acetate Chemical compound CC(C)C1CCC(C)(OC(C)=O)CC1 PXLKJWMSFPYVNB-UHFFFAOYSA-N 0.000 description 1
- PKMTWMDBJHRDBM-ODZAUARKSA-N (z)-but-2-enedioic acid;zinc Chemical compound [Zn].OC(=O)\C=C/C(O)=O PKMTWMDBJHRDBM-ODZAUARKSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- RPZANUYHRMRTTE-UHFFFAOYSA-N 2,3,4-trimethoxy-6-(methoxymethyl)-5-[3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxyoxane;1-[[3,4,5-tris(2-hydroxybutoxy)-6-[4,5,6-tris(2-hydroxybutoxy)-2-(2-hydroxybutoxymethyl)oxan-3-yl]oxyoxan-2-yl]methoxy]butan-2-ol Chemical compound COC1C(OC)C(OC)C(COC)OC1OC1C(OC)C(OC)C(OC)OC1COC.CCC(O)COC1C(OCC(O)CC)C(OCC(O)CC)C(COCC(O)CC)OC1OC1C(OCC(O)CC)C(OCC(O)CC)C(OCC(O)CC)OC1COCC(O)CC RPZANUYHRMRTTE-UHFFFAOYSA-N 0.000 description 1
- RADIRXJQODWKGQ-HWKANZROSA-N 2-Ethoxy-5-(1-propenyl)phenol Chemical compound CCOC1=CC=C(\C=C\C)C=C1O RADIRXJQODWKGQ-HWKANZROSA-N 0.000 description 1
- RCORSHSFJCXHTF-UHFFFAOYSA-N 2-ethenyl-1,3-dioxan-5-ol Chemical compound OC1COC(C=C)OC1 RCORSHSFJCXHTF-UHFFFAOYSA-N 0.000 description 1
- UBLAMKHIFZBBSS-UHFFFAOYSA-N 3-Methylbutyl pentanoate Chemical compound CCCCC(=O)OCCC(C)C UBLAMKHIFZBBSS-UHFFFAOYSA-N 0.000 description 1
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 1
- OZJPLYNZGCXSJM-UHFFFAOYSA-N 5-valerolactone Chemical compound O=C1CCCCO1 OZJPLYNZGCXSJM-UHFFFAOYSA-N 0.000 description 1
- RFRMMZAKBNXNHE-UHFFFAOYSA-N 6-[4,6-dihydroxy-5-(2-hydroxyethoxy)-2-(hydroxymethyl)oxan-3-yl]oxy-2-(hydroxymethyl)-5-(2-hydroxypropoxy)oxane-3,4-diol Chemical compound CC(O)COC1C(O)C(O)C(CO)OC1OC1C(O)C(OCCO)C(O)OC1CO RFRMMZAKBNXNHE-UHFFFAOYSA-N 0.000 description 1
- 229910002012 Aerosil® Inorganic materials 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 241000206575 Chondrus crispus Species 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- UDIPTWFVPPPURJ-UHFFFAOYSA-M Cyclamate Chemical compound [Na+].[O-]S(=O)(=O)NC1CCCCC1 UDIPTWFVPPPURJ-UHFFFAOYSA-M 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- QSJXEFYPDANLFS-UHFFFAOYSA-N Diacetyl Chemical group CC(=O)C(C)=O QSJXEFYPDANLFS-UHFFFAOYSA-N 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 1
- 244000004281 Eucalyptus maculata Species 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 240000001238 Gaultheria procumbens Species 0.000 description 1
- 235000007297 Gaultheria procumbens Nutrition 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- NFLGAXVYCFJBMK-UHFFFAOYSA-N Menthone Chemical compound CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 description 1
- SOWBFZRMHSNYGE-UHFFFAOYSA-N Monoamide-Oxalic acid Natural products NC(=O)C(O)=O SOWBFZRMHSNYGE-UHFFFAOYSA-N 0.000 description 1
- 244000227633 Ocotea pretiosa Species 0.000 description 1
- 235000004263 Ocotea pretiosa Nutrition 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical class [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 241000282320 Panthera leo Species 0.000 description 1
- XCOJIVIDDFTHGB-UEUZTHOGSA-N Perillartine Chemical compound CC(=C)[C@H]1CCC(\C=N\O)=CC1 XCOJIVIDDFTHGB-UEUZTHOGSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920000388 Polyphosphate Polymers 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 229910002054 SYLOID® 244 FP SILICA Inorganic materials 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 239000004141 Sodium laurylsulphate Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- IPBVNPXQWQGGJP-UHFFFAOYSA-N acetic acid phenyl ester Natural products CC(=O)OC1=CC=CC=C1 IPBVNPXQWQGGJP-UHFFFAOYSA-N 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 description 1
- 239000004964 aerogel Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229940011037 anethole Drugs 0.000 description 1
- 229920006318 anionic polymer Polymers 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- YLZSIUVOIFJGQZ-UHFFFAOYSA-N bis[4-(dimethylamino)phenyl]methanol Chemical compound C1=CC(N(C)C)=CC=C1C(O)C1=CC=C(N(C)C)C=C1 YLZSIUVOIFJGQZ-UHFFFAOYSA-N 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- XFWJKVMFIVXPKK-UHFFFAOYSA-N calcium;oxido(oxo)alumane Chemical class [Ca+2].[O-][Al]=O.[O-][Al]=O XFWJKVMFIVXPKK-UHFFFAOYSA-N 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 230000009918 complex formation Effects 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000000625 cyclamic acid and its Na and Ca salt Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 210000004268 dentin Anatomy 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- FSBVERYRVPGNGG-UHFFFAOYSA-N dimagnesium dioxido-bis[[oxido(oxo)silyl]oxy]silane hydrate Chemical compound O.[Mg+2].[Mg+2].[O-][Si](=O)O[Si]([O-])([O-])O[Si]([O-])=O FSBVERYRVPGNGG-UHFFFAOYSA-N 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- CQAIPTBBCVQRMD-UHFFFAOYSA-L dipotassium;phosphono phosphate Chemical compound [K+].[K+].OP(O)(=O)OP([O-])([O-])=O CQAIPTBBCVQRMD-UHFFFAOYSA-L 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000019820 disodium diphosphate Nutrition 0.000 description 1
- GYQBBRRVRKFJRG-UHFFFAOYSA-L disodium pyrophosphate Chemical compound [Na+].[Na+].OP([O-])(=O)OP(O)([O-])=O GYQBBRRVRKFJRG-UHFFFAOYSA-L 0.000 description 1
- 229940038485 disodium pyrophosphate Drugs 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 229940073505 ethyl vanillin Drugs 0.000 description 1
- 239000001902 eugenia caryophyllata l. bud oil Substances 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 229910021485 fumed silica Inorganic materials 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 235000012171 hot beverage Nutrition 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 235000001055 magnesium Nutrition 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical class [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 235000011160 magnesium carbonates Nutrition 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229940099273 magnesium trisilicate Drugs 0.000 description 1
- 229910000386 magnesium trisilicate Inorganic materials 0.000 description 1
- 235000019793 magnesium trisilicate Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- MBKDYNNUVRNNRF-UHFFFAOYSA-N medronic acid Chemical compound OP(O)(=O)CP(O)(O)=O MBKDYNNUVRNNRF-UHFFFAOYSA-N 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229930007503 menthone Natural products 0.000 description 1
- 125000005341 metaphosphate group Chemical class 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- 229940051866 mouthwash Drugs 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000002903 organophosphorus compounds Chemical class 0.000 description 1
- KZNNRLXBDAAMDZ-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane trihydrate Chemical compound O.O.O.O=[Al]O[Al]=O KZNNRLXBDAAMDZ-UHFFFAOYSA-N 0.000 description 1
- 229930004008 p-menthane Natural products 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 1
- 239000010663 parsley oil Substances 0.000 description 1
- 229940049953 phenylacetate Drugs 0.000 description 1
- SATCULPHIDQDRE-UHFFFAOYSA-N piperonal Chemical compound O=CC1=CC=C2OCOC2=C1 SATCULPHIDQDRE-UHFFFAOYSA-N 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229940093430 polyethylene glycol 1500 Drugs 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 239000001205 polyphosphate Substances 0.000 description 1
- 235000011176 polyphosphates Nutrition 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000011698 potassium fluoride Substances 0.000 description 1
- 235000003270 potassium fluoride Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 239000001296 salvia officinalis l. Substances 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229960001462 sodium cyclamate Drugs 0.000 description 1
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical class [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 1
- YKOLYTVUIVUUDY-UHFFFAOYSA-K sodium;zinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Na+].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O YKOLYTVUIVUUDY-UHFFFAOYSA-K 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- RYCLIXPGLDDLTM-UHFFFAOYSA-J tetrapotassium;phosphonato phosphate Chemical class [K+].[K+].[K+].[K+].[O-]P([O-])(=O)OP([O-])([O-])=O RYCLIXPGLDDLTM-UHFFFAOYSA-J 0.000 description 1
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229920001187 thermosetting polymer Polymers 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- VVGOCOMZRGWHPI-UHFFFAOYSA-N trans-hept-4-enal Natural products CCC=CCCC=O VVGOCOMZRGWHPI-UHFFFAOYSA-N 0.000 description 1
- 239000009637 wintergreen oil Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000004246 zinc acetate Substances 0.000 description 1
- 229960000314 zinc acetate Drugs 0.000 description 1
- 235000013904 zinc acetate Nutrition 0.000 description 1
- 229940056904 zinc ascorbate Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- WWRJFSIRMWUMAE-ZZMNMWMASA-L zinc;(2r)-2-[(1s)-1,2-dihydroxyethyl]-3-hydroxy-5-oxo-2h-furan-4-olate Chemical compound [Zn+2].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] WWRJFSIRMWUMAE-ZZMNMWMASA-L 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 229910052726 zirconium Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/27—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Definitions
- the present invention relates to dentifrices, particularly to toothpastes and more particularly to toothpastes that contain zinc salts, while exhibiting lower astringency.
- EP0162574 (1985, Johnson & Johnson) describes the reduction of astringency by the use of pluronic type of polymers, i.e. polyethylene oxide - polypropylene oxide block copolymers as surfactants. The present inventors have found that while this provides for reduction of astringency, it remains a costly option. Similarly, EP0251542 (1988, Lion Corporation) describes reduction of astringency of zinc salts by the use of polyoxyethylene-hydrogenated castor oil.
- the present inventors have found that the astringent aftereffect associated with dentifrice compositions containing zinc salts can be reduced to a significant extent by the use of a polyethylene oxide and a humectant.
- compositions exhibited significant reduction in astringency
- compositions also offered protection against oral malodour for a significantly longer period of time upon continued usage.
- a dentifrice composition that includes: (i) 0.1 to 5 % by weight zinc salt; (ii) 0.01 to 1.0 % by weight polyethylene oxide having molecular weight of from 100,000 to 8,000,000 g/mol; and
- it includes 0.1 to 2 % by weight zinc salt.
- the composition includes 0.1 to 0.5 % by weight polyethylene oxide of molecular weight from 100,000 to 8,000,000 g/mol.
- the high molecular weight polyethylene oxide for use according to the invention should be understood to mean polyethylene oxide of molecular weight from 100,000 to 8,000,000 g/mol.
- the zinc salt is selected from zinc chloride, zinc sulphate or zinc citrate, more preferably it is zinc sulphate .
- a process for making a dentifrice composition that includes mixing 0.1 to 5 parts by weight zinc salt with 0.01 to 1 parts by weight polyethylene oxide having molecular weight of from 100,000 to 8,000,000 g/mol and 10 to 70 parts by weight humectant, with a suitable vehicle.
- dentifrice means a substance for cleaning the teeth which is suitable for application with a toothbrush and is rinsed off after use. It can be a paste, gel, or liquid formulation. Dentifrice compositions herein can be single, dual or multi phase preparations such as deep striped, surface striped, multilayered, core in sheath, for example having gel surrounding paste, or any combination thereof .
- a single phase may include a liquid carrier with one or more insoluble particles, such as of a dental abrasive, homogeneously dispersed within it.
- the dentifrice composition comprises more than one phase
- said phases may be contained in physically separated compartments of a dispenser and dispensed side-by-side or they may contained in packaging in which they are in direct contact .
- An essential component of the dentifrice compositions according to the invention is a zinc salt.
- Zinc salts are effective as antimicrobial agents.
- the zinc salt preferably has a solubility of at least 0. Ig per lOOg water but insoluble materials such as zinc oxide can provide soluble zinc salts if used in conjunction with other solubilizing materials, such sodium citrate.
- Zinc salts useful in the present invention include zinc chloride, zinc sulphate, zinc nitrate, zinc citrate, zinc gluconate, zinc acetate, zinc lactate and zinc salicylate. Mixed salts such as sodium zinc citrate can also be used.
- Preferred zinc salts are zinc salts of organic acids such as zinc citrate, zinc lactate, zinc maleate, zinc salicylate, zinc gluconate and zinc ascorbate.
- the most preferred salt is Zinc sulphate. Mixtures of different zinc salts can be used.
- the zinc salt is preferably incorporated in the oral care composition of the present invention at a concentration of about 0.1 to 5 % by weight and preferably about 0.1 to about 2% by weight and most preferably, the zinc salt level is from 0.1 to 0.5% by weight. Excess amounts of zinc will lead to unacceptable taste and higher level of astringency and may cause problems of compatibility with other ingredients such as e.g., precipitation of anionic polymers.
- the polyethylene oxide having molecular weight of from 100,000 to 8,000,000 g/mol used in the present invention affords a slippery feel to the oral cavity and thereby re- lubricates the mouth.
- the molecular weight is from 600,000 to 2,000,000 g/mol, and more preferably from 800,000 to 1,000,000 g/mol.
- POLYOX ® is the trade name for a high molecular weight polyethylene oxide produced by Dow Chemicals. A particularly preferred material is available from Dow Chemicals as POLYOX ® WSR 301-NF.
- Useful levels of the high molecular weight polyethylene oxide for use according to the invention are from about 0.01% to about 1%, preferably from about 0.1% to about 0.5 % and most preferably 0.1 % to 0.2 % by weight of the composition. Additional level of such polyethylene oxide was observed to present problems with its dispersion in the medium.
- the dentifrice composition according to the invention includes a humectant which enhances flavour, prevents harsh taste and provides a fresh and pleasant sensation in the mouth. It also prevents caking of the dentifrice.
- the humectant serves to keep the dentifrice compositions from hardening upon exposure to air and may also impart a desirable sweetness to the formulations to further minimize the astringency ascribed to the zinc salt.
- Humectant is preferably present in a total amount of about 10-70%, more preferably about 25-60% by weight.
- Typical humectants include sorbitol (typically added as 70% aqueous solution) , glycerine, maltitol and xylitol.
- the dentifrice contains about 16-30% glycerine in an opaque cream base, while a combination of 10 to 30 wt% glycerine and 30 to 50 wt% sorbitol (as 70% aqueous solution) is used for clear gel compositions.
- a gel composition comprising 20 wt% glycerine and 40 wt% sorbitol (as 70% aqueous solution) would comprise humectant in a total amount of 48 wt% (20+ [40x0.70 ] ) , assuming no other humectants present.
- Sorbitol solution supplies sweetness and body to the composition and gives a desirable mouth feel. It is preferred that a mixture of glycerine and sorbitol is used for a lubricated mouth feel.
- an effective amount of sweetener is utilized to provide the level of sweetness desired. This amount will vary with the sweetener selected and the composition.
- the amount of sweetener normally present is from about 0.0025 % by weight to about 60 % by weight of the dentifrice composition .
- water is generally not present at more than 10%, typically about 2-5% by weight.
- water employed in the preparation of commercially suitable dentifrices should preferably be deionised and free of impurities. Water comprises from about 0.05 to 70.0%, preferably from about 15.0 to 50.0% by weight of the formulations. These amounts of water include the free water which is added and also that which is introduced with other materials, such as 70% aqueous sorbitol solution.
- the liquid phase of the composition of the present invention is preferably formulated such that its refractive index closely matches the refractive index of the silicas which are also present in the composition.
- the liquid phase usually comprises water and a humectant, the latter usually being sorbitol or glycerol.
- Water has an RI (refractive index) of 1.333; sorbitol (70% aqueous solution) has an RI of 1.457 and glycerine has an RI of 1.473.
- the refractive index of the liquid phase can be calculated from the respective refractive indices of the constituting ingredients.
- compositions of the invention may contain further optional ingredients, as long as the clarity of the dentifrices, when in gel form, is thereby not impaired and the RI of the liquid phase is about the RI of the low refractive index abrasive silica.
- Another preferred ingredient is a water-soluble fluoride compound, used in an amount sufficient to give a fluoride concentration in the composition of from about 0.0025% to about 0.5% by weight, to provide anti-caries effectiveness.
- fluoride ion-yielding materials can be employed as sources of soluble fluoride in the present compositions.
- Representative fluoride ion sources include stannous fluoride, sodium fluoride, potassium fluoride, sodium monofluorophosphate and many others. Stannous fluoride and sodium fluoride are particularly preferred, as well as mixtures thereof.
- sodium fluoride is used in combination with the long chain polyphosphates then it is preferably kept in a separate phase.
- the dentifrices of the invention may also contain coloured particles suspended therein, e.g. coloured silica agglomerates or other coloured particles to impart a "speckled" appearance to the dentifrices.
- the colouring agent may be in the form of an aqueous solution, preferably 1% colouring agent in a solution of water. Colour solutions generally comprise from 0.01% to 5% by weight of the composition .
- Titanium dioxide may also be added to the present composition. Titanium dioxide is a white powder which adds opacity to the compositions. Titanium dioxide may comprise from 0.25% to 5%, by weight of the composition.
- further gelling or binding agent such as organic thickeners of natural and synthetic gums may be incorporated in the compositions of the present invention.
- organic thickeners are carrageenan (Irish moss), xanthan gum, sodium carboxymethyl cellulose, starch, polyvinylpyrrolidone, hydroxyethylpropylcellulose, hydroxybutyl methyl cellulose, hydroxypropyl methyl cellulose, and hydroxyethyl cellulose.
- compositions according to the invention may also include polyethylene oxide of molecular weight less than 100,000.
- Such materials for example polyethylene glycol 1500, are often included to improve the cohesion of the composition.
- the organic thickener may be incorporated in the compositions of the present invention at a concentration of 10 about 0.25 to about 2% by weight and preferably about 0.5 to about 1% by weight of the composition.
- Synthetic finely divided pyrogenic silica such as those sold under the trademarks CAB-O-SIL ® M-5, SYLOID ® 244, SYLOID ® 266 and AEROSIL ® D-200 may also be employed in amounts of about 1-5% by weight to promote thickening or gelling of the dentifrice .
- Antibacterial agents commonly known in the art may also be employed in the dentifrice compositions of the instant invention to provide a total content of such agents of up to about 5% by weight.
- flavouring or sweetening materials include the flavouring oils, e.g. oils of spearmint, peppermint, wintergreen, sassafras, clove, sage, eucalyptus, marjoram, cinnamon, lemon and orange as well as methylsalicylate, oil of wintergreen, oil of peppermint, oil of spearmint, clove bud oil, menthol, anethole, methyl salicylate, eucalyptol, cassia, 1-menthyl acetate, sage, eugenol, parsley oil, oxanone, alpha-irisone, marjoram, lemon, orange, propenyl guaethol, cinnamon, vanillin, ethyl vanillin, heliotropine, 4-cis-heptenal, diacetyl, methyl-para-tert-butyl phenyl acetate,
- a flavour system is generally used in the compositions at levels of from 0.001% to 5%, by weight of the composition. Addition of the flavour takes care of the metallic aftertaste of Zinc salts.
- the composition further preferably includes a coolant.
- coolants in the present compositions are the paramenthane carboxyamide agents such as N-ethyl-p-menthan- 3-carboxamide, (known commercially as “WS-3”) and mixtures thereof and menthone glycerine acetal (known commercially as "MGA”) .
- Suitable sweetening agents include sucrose, lactose, maltose, sorbitol, sodium cyclamate, perillartine, and saccharine.
- the present invention may also include xylitol.
- Xylitol is a sugar alcohol that is used as a sweetener and humectant. Xylitol may provide a therapeutic effect, such as an antibacterial or anticaries effect.
- compositions typically comprise xylitol at a level from 0.01% to 25%, preferably from 3% to 15%, more preferably from 5% to 12%, and most preferably from 9% to 11% by weight of the total composition.
- xylitol is used as a sweetener, it may be present at a lower level, such as from 0.005% to 5%, by weight of the dentifrice composition.
- Surfactant levels cited herein are on a 100% active basis, even though common raw materials such as sodium lauryl sulphate may be supplied as aqueous solutions of lower activity.
- the surfactant is important for oral cleaning, both thorough removal of dirt from surfaces and in foam generation to suspend removed dirt.
- Suitable surfactant levels are from about 2% to about 15%, preferably from about 2.2% to about 10%, more preferably from about 2.5 to about 5% by weight of the total composition.
- Suitable surfactants for use herein include anionic, amphoteric, non-ionic, zwitterionic and cationic surfactants, though anionic, amphoteric, non-ionic and zwitterionic surfactants (and mixtures thereof) are preferred.
- Abrasives is normally included in the composition.
- Abrasives may be selected from water-insoluble alkali or alkaline earth metal salts of metaphosphate, calcium carbonate, aluminate and silicate. Especially preferred are silica, dicalcium phosphate and calcium carbonate. Amount of the abrasive range from about 5 to about 80% by weight of the composition. Also suitable are chalk-type abrasives such as calcium and magnesium carbonates, silicas including xerogels, hydrogels, aerogels and precipitates, alumina and hydrates thereof.
- Abrasives include alpha alumina trihydrate, aluminosilicates such as calcined aluminium silicate and aluminium silicate, magnesium and zirconium silicates such as magnesium trisilicate and thermosetting polymerised resins such as particulate condensation products of urea and formaldehyde, polymethylmethacrylate, powdered polyethylene. Mixtures of abrasives can also be used.
- the abrasive polishing materials generally have an average particle size of from about 0.1 to about 30 microns, preferably from about 5 to 15 microns.
- Silica dental abrasives of various types offer exceptional dental cleaning and polishing performance without unduly abrading tooth enamel or dentin.
- the silica abrasive can be precipitated silica or silica gels for example silica xerogels marketed under the trade name SYLOID ® by W. R. Grace & Company, Davison Chemical Division.
- Suitable precipitated silica materials include those marketed by the J. M. Huber Corporation under the trade name, ZEODENT ® 119 or ZEODENT ® 118.
- Suitable abrasive levels are from about 1% to about 40%, preferably at least about 2%, such as from about 2% to about 20%, more preferably at least about 5%, such as from about 5% to about 15% by weight of the composition.
- Tartar control agents may be incorporated into compositions of this invention, especially effective are agents containing phosphorous.
- Inorganic phosphorous tartar control agents may include any of the water-soluble pyrophosphates such as disodium pyrophosphate, dipotassium pyrophosphate and mixtures of these with tetrapotassium pyrophosphates or tetrasodium pyrophosphates.
- Organic phosphorous compounds that may serve as tartar control agents include polyphosphonates such as disodium ethane-l-hydroxy-1, 1-diphosphonate (EHDP) and methanediphosphonic acid.
- polyphosphonates such as disodium ethane-l-hydroxy-1, 1-diphosphonate (EHDP) and methanediphosphonic acid.
- compositions according to the invention have a pH in the range of 5 to 8, preferably 6.5 to 7.5, e.g. 7.
- the present invention also relates to a process for making a dentifrice composition that includes mixing 0.1 to 5 parts by weight zinc salt with 0.01 to 1 parts by weight polyethylene oxide having molecular weight of from 100,000 to 8,000,000 g/mol and 10 to 70 parts by weight humectant, with a suitable vehicle.
- humectants such as glycerine and sorbitol
- the high molecular polyethylene oxide for use according to the invention for use according to the invention
- zinc salt to water and mix for 10 to 15 minutes in a conventional mixer.
- optional ingredients e.g. silica and carboxymethylcellulose
- surfactants e.g. sodium silica and sodium bicarbonate
- the mix may then be de-aerated under vacuum.
- Flavour and colour ingredients may then be added and mixing continued for a further 10-15 minutes and further de- aeratation under vacuum.
- the resultant product is typically a stable dentifrice of texture like that of normal gels and of satisfactory flavour.
- composition -1 A core and sheath type of toothpaste was made with the core and the sheath being a gel.
- the ingredients of the composition (Composition -1) have been listed in table-1.
- organoleptic judges participated in scoring the volunteers. These judges were also asked to refrain from drinking hot beverages, smoking, consuming alcohol or using cosmetics during the study. Each volunteer was asked to close the mouth for 60 seconds and not swallow during this period. After one minute the volunteer breathed out the mouth air gently through a diameter of 24mm / length 5 cm tube at a distance of approximately 10 cm from the nose of the odour judge who were hidden behind the screen and would immediately record the odour on a 0-5 organoleptic scale.
- the organoleptic scale of 0 to 5 was as follows: 0 No odour present
- Odour is of low intensity and within organoleptically acceptable limits.
- Composition-1 offers a significant reduction in oral malodour level on day-1 itself, even after two hours of brushing.
- composition-1 offers significant reduction in malodour level even before brushing (i.e. after 12 hours from the last brushing, overnight) on 4 weeks of continued use (twice daily) and the difference between the placebo score and that of composition-1 after 2 hours of brushing in this case is very significant. This therefore, goes to - I i
- composition is capable of offering protection against oral malodour for a significantly longer period of time upon continued usage.
- VSC Volatile Sulphur Content
- Oral malodour measurements were made on each volunteer using the Halimeter. On the morning of each test, the volunteers did not consume any food/confectionery or use any mouthwash prior to their baseline assessment. Volunteers abstained from eating and drinking for the duration of each visit. After the baseline assessment, volunteers were made to brush one full brush length with the appropriate dentifrice for 2 minutes. Oral malodour measurements were made using the InterScan Halimeter Model RH-17K (standard Operating Procedure) at 12 hours before brushing, 10 minutes after brushing and 2 hours post brushing.
- composition-1 is Composition-1
- compositions containing 0.2, 0.4 and 0.7% zinc sulphate were made in which the formulations were identical to that in Table-1, except for the increased/decreased levels of zinc Sulphate, with a corresponding increase/decrease in the content of water in the corresponding formulations.
- Efficacy of the dentifrices was evaluated by studying BDCOH (4 , 4 ' -bis (dimethylamino) diphenylcarbinol) levels in saliva, pre and post brushing. This is also an indicator of the level of malodour.
- compositions according to the invention also provide other desirable consumer benefits.
- composition Comparative Example 1
- Comparative Example 1 The following composition, Comparative Example 1, was prepared and was used by 200 volunteers for a period of 1 week, twice daily. Thereafter, they rated the composition for various consumer desirable benefits, as being on parity or better than the composition according to the invention as in table-1.
- composition 1 in accordance with the invention is able to meet most of the desirable consumer attributes, when compared to a formulation devoid of high molecular weight polyethylene oxide in accordance.
- Composition-1 and Comparative Example-1 were also compared by 15 expert panel members.
- the aim of this study was to evaluate and compare the mouth feel, foam levels, flavour intensity and flavour related attributes.
- Panellists brushed their teeth with one full brush length for 60 seconds. They assessed the various attributes using the line scale from 0 to 10, zero being the lowest and 10 being the highest score. Average results of their comparative assessment have been compiled in the following table-8.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Cosmetics (AREA)
Abstract
A dentifrice composition that includes: iv) 0.1 to 5% by weight zincsalt; v) 0.01 to 1.0% by weight polyethylene oxide having molecular weight of from 100,000 to 8,000,000 g/mol; and vi)10 to 70% by weight of a humectant.
Description
DENTIFRICE COMPOSITION
The present invention relates to dentifrices, particularly to toothpastes and more particularly to toothpastes that contain zinc salts, while exhibiting lower astringency.
Any discussion of the prior art throughout the specification should in no way be considered as an admission that such prior art is widely known or forms part of the common general knowledge in the field.
The incorporation of zinc salts into dentifrice compositions to beneficially reduce oral malodour is well known in the art. However, the astringency of zinc salts is a major drawback in its use in dentifrice compositions creating an unpleasant astringent taste in the mouth. In addition, the efficacy against plaque, calculus and odour development is short-lived. Usually, complex formation of zinc with anionic counter ions, such as citrate, reduces its astringency but also reduces its solubility and/or biological availability.
Various attempts have been made in the past to overcome and/or reduce the astringency of dentifrices containing zinc salts .
EP0162574 (1985, Johnson & Johnson) describes the reduction of astringency by the use of pluronic type of polymers, i.e. polyethylene oxide - polypropylene oxide block copolymers as surfactants. The present inventors have found that while this provides for reduction of astringency, it remains a costly option.
Similarly, EP0251542 (1988, Lion Corporation) describes reduction of astringency of zinc salts by the use of polyoxyethylene-hydrogenated castor oil.
There is a need for newer and better ways of reducing the astringent effect of dentifrice compositions containing zinc salts .
It is an object of the present invention to provide for a dentifrice composition that includes zinc salts, while having relatively lower astringency.
It is an object of the present invention to provide a dentifrice composition that offers enhanced level of breath freshness .
The present inventors have found that the astringent aftereffect associated with dentifrice compositions containing zinc salts can be reduced to a significant extent by the use of a polyethylene oxide and a humectant.
The present inventors have surprisingly observed that while the compositions exhibited significant reduction in astringency, the compositions also offered protection against oral malodour for a significantly longer period of time upon continued usage.
According to an aspect of the present invention, there is provided a dentifrice composition that includes: (i) 0.1 to 5 % by weight zinc salt;
(ii) 0.01 to 1.0 % by weight polyethylene oxide having molecular weight of from 100,000 to 8,000,000 g/mol; and
(iii) 10 to 70 % by weight of a humectant.
Preferably, it includes 0.1 to 2 % by weight zinc salt.
Preferably the composition includes 0.1 to 0.5 % by weight polyethylene oxide of molecular weight from 100,000 to 8,000,000 g/mol.
Throughout this specification, reference to "the high molecular weight polyethylene oxide for use according to the invention" should be understood to mean polyethylene oxide of molecular weight from 100,000 to 8,000,000 g/mol.
Preferably the zinc salt is selected from zinc chloride, zinc sulphate or zinc citrate, more preferably it is zinc sulphate .
According to another aspect of the present invention, there is provided a process for making a dentifrice composition that includes mixing 0.1 to 5 parts by weight zinc salt with 0.01 to 1 parts by weight polyethylene oxide having molecular weight of from 100,000 to 8,000,000 g/mol and 10 to 70 parts by weight humectant, with a suitable vehicle.
According to another aspect of the present invention there is provided use of a dentifrice composition according to the invention.
The term "dentifrice", as used herein, means a substance for cleaning the teeth which is suitable for application with a toothbrush and is rinsed off after use. It can be a paste, gel, or liquid formulation. Dentifrice compositions herein can be single, dual or multi phase preparations such as deep striped, surface striped, multilayered, core in sheath, for example having gel surrounding paste, or any combination thereof .
A single phase may include a liquid carrier with one or more insoluble particles, such as of a dental abrasive, homogeneously dispersed within it.
When the dentifrice composition comprises more than one phase, said phases may be contained in physically separated compartments of a dispenser and dispensed side-by-side or they may contained in packaging in which they are in direct contact .
An essential component of the dentifrice compositions according to the invention is a zinc salt. Zinc salts are effective as antimicrobial agents.
The zinc salt preferably has a solubility of at least 0. Ig per lOOg water but insoluble materials such as zinc oxide can provide soluble zinc salts if used in conjunction with other solubilizing materials, such sodium citrate.
Zinc salts useful in the present invention include zinc chloride, zinc sulphate, zinc nitrate, zinc citrate, zinc gluconate, zinc acetate, zinc lactate and zinc salicylate.
Mixed salts such as sodium zinc citrate can also be used. Preferred zinc salts are zinc salts of organic acids such as zinc citrate, zinc lactate, zinc maleate, zinc salicylate, zinc gluconate and zinc ascorbate. However, the most preferred salt is Zinc sulphate. Mixtures of different zinc salts can be used. The zinc salt is preferably incorporated in the oral care composition of the present invention at a concentration of about 0.1 to 5 % by weight and preferably about 0.1 to about 2% by weight and most preferably, the zinc salt level is from 0.1 to 0.5% by weight. Excess amounts of zinc will lead to unacceptable taste and higher level of astringency and may cause problems of compatibility with other ingredients such as e.g., precipitation of anionic polymers.
While not wishing to be bound by any theory, it is believed that the polyethylene oxide having molecular weight of from 100,000 to 8,000,000 g/mol used in the present invention affords a slippery feel to the oral cavity and thereby re- lubricates the mouth. Preferably, the molecular weight is from 600,000 to 2,000,000 g/mol, and more preferably from 800,000 to 1,000,000 g/mol. "POLYOX®" is the trade name for a high molecular weight polyethylene oxide produced by Dow Chemicals. A particularly preferred material is available from Dow Chemicals as POLYOX® WSR 301-NF. Useful levels of the high molecular weight polyethylene oxide for use according to the invention are from about 0.01% to about 1%, preferably from about 0.1% to about 0.5 % and most preferably 0.1 % to 0.2 % by weight of the composition. Additional level of such polyethylene oxide was observed to present problems with its dispersion in the medium.
The dentifrice composition according to the invention includes a humectant which enhances flavour, prevents harsh taste and provides a fresh and pleasant sensation in the mouth. It also prevents caking of the dentifrice. The humectant serves to keep the dentifrice compositions from hardening upon exposure to air and may also impart a desirable sweetness to the formulations to further minimize the astringency ascribed to the zinc salt. Humectant is preferably present in a total amount of about 10-70%, more preferably about 25-60% by weight. Typical humectants include sorbitol (typically added as 70% aqueous solution) , glycerine, maltitol and xylitol. Most preferably the dentifrice contains about 16-30% glycerine in an opaque cream base, while a combination of 10 to 30 wt% glycerine and 30 to 50 wt% sorbitol (as 70% aqueous solution) is used for clear gel compositions. For the avoidance of doubt, a gel composition comprising 20 wt% glycerine and 40 wt% sorbitol (as 70% aqueous solution) would comprise humectant in a total amount of 48 wt% (20+ [40x0.70 ] ) , assuming no other humectants present.
Sorbitol solution supplies sweetness and body to the composition and gives a desirable mouth feel. It is preferred that a mixture of glycerine and sorbitol is used for a lubricated mouth feel.
In general, an effective amount of sweetener is utilized to provide the level of sweetness desired. This amount will vary with the sweetener selected and the composition.
The amount of sweetener normally present is from about 0.0025 % by weight to about 60 % by weight of the dentifrice composition .
When a substantially visually clear gel is desired, water is generally not present at more than 10%, typically about 2-5% by weight. When the dentifrice is opaque, greater amounts of water may be present. Water employed in the preparation of commercially suitable dentifrices should preferably be deionised and free of impurities. Water comprises from about 0.05 to 70.0%, preferably from about 15.0 to 50.0% by weight of the formulations. These amounts of water include the free water which is added and also that which is introduced with other materials, such as 70% aqueous sorbitol solution.
For a transparent dentifrice, the liquid phase of the composition of the present invention is preferably formulated such that its refractive index closely matches the refractive index of the silicas which are also present in the composition. The liquid phase usually comprises water and a humectant, the latter usually being sorbitol or glycerol. Water has an RI (refractive index) of 1.333; sorbitol (70% aqueous solution) has an RI of 1.457 and glycerine has an RI of 1.473. The refractive index of the liquid phase can be calculated from the respective refractive indices of the constituting ingredients.
The compositions of the invention may contain further optional ingredients, as long as the clarity of the dentifrices, when in gel form, is thereby not impaired and
the RI of the liquid phase is about the RI of the low refractive index abrasive silica.
Another preferred ingredient is a water-soluble fluoride compound, used in an amount sufficient to give a fluoride concentration in the composition of from about 0.0025% to about 0.5% by weight, to provide anti-caries effectiveness. A wide variety of fluoride ion-yielding materials can be employed as sources of soluble fluoride in the present compositions. Representative fluoride ion sources include stannous fluoride, sodium fluoride, potassium fluoride, sodium monofluorophosphate and many others. Stannous fluoride and sodium fluoride are particularly preferred, as well as mixtures thereof.
If, however, sodium fluoride is used in combination with the long chain polyphosphates then it is preferably kept in a separate phase.
The dentifrices of the invention may also contain coloured particles suspended therein, e.g. coloured silica agglomerates or other coloured particles to impart a "speckled" appearance to the dentifrices. The colouring agent may be in the form of an aqueous solution, preferably 1% colouring agent in a solution of water. Colour solutions generally comprise from 0.01% to 5% by weight of the composition .
Titanium dioxide may also be added to the present composition. Titanium dioxide is a white powder which adds
opacity to the compositions. Titanium dioxide may comprise from 0.25% to 5%, by weight of the composition.
In addition to the high molecular weight polyethylene oxide for use according to the invention, further gelling or binding agent such as organic thickeners of natural and synthetic gums may be incorporated in the compositions of the present invention. Examples of such thickeners are carrageenan (Irish moss), xanthan gum, sodium carboxymethyl cellulose, starch, polyvinylpyrrolidone, hydroxyethylpropylcellulose, hydroxybutyl methyl cellulose, hydroxypropyl methyl cellulose, and hydroxyethyl cellulose.
Compositions according to the invention may also include polyethylene oxide of molecular weight less than 100,000. Such materials, for example polyethylene glycol 1500, are often included to improve the cohesion of the composition.
The organic thickener may be incorporated in the compositions of the present invention at a concentration of 10 about 0.25 to about 2% by weight and preferably about 0.5 to about 1% by weight of the composition. Synthetic finely divided pyrogenic silica such as those sold under the trademarks CAB-O-SIL® M-5, SYLOID® 244, SYLOID® 266 and AEROSIL® D-200 may also be employed in amounts of about 1-5% by weight to promote thickening or gelling of the dentifrice .
Antibacterial agents commonly known in the art may also be employed in the dentifrice compositions of the instant
invention to provide a total content of such agents of up to about 5% by weight.
The taste of the composition may be modified by employing suitable flavouring or sweetening materials. Examples of suitable flavouring constituents include the flavouring oils, e.g. oils of spearmint, peppermint, wintergreen, sassafras, clove, sage, eucalyptus, marjoram, cinnamon, lemon and orange as well as methylsalicylate, oil of wintergreen, oil of peppermint, oil of spearmint, clove bud oil, menthol, anethole, methyl salicylate, eucalyptol, cassia, 1-menthyl acetate, sage, eugenol, parsley oil, oxanone, alpha-irisone, marjoram, lemon, orange, propenyl guaethol, cinnamon, vanillin, ethyl vanillin, heliotropine, 4-cis-heptenal, diacetyl, methyl-para-tert-butyl phenyl acetate, and mixtures thereof.
A flavour system is generally used in the compositions at levels of from 0.001% to 5%, by weight of the composition. Addition of the flavour takes care of the metallic aftertaste of Zinc salts.
The composition further preferably includes a coolant. Preferred coolants in the present compositions are the paramenthane carboxyamide agents such as N-ethyl-p-menthan- 3-carboxamide, (known commercially as "WS-3") and mixtures thereof and menthone glycerine acetal (known commercially as "MGA") .
Suitable sweetening agents include sucrose, lactose, maltose, sorbitol, sodium cyclamate, perillartine, and
saccharine. The present invention may also include xylitol. Xylitol is a sugar alcohol that is used as a sweetener and humectant. Xylitol may provide a therapeutic effect, such as an antibacterial or anticaries effect.
The present compositions typically comprise xylitol at a level from 0.01% to 25%, preferably from 3% to 15%, more preferably from 5% to 12%, and most preferably from 9% to 11% by weight of the total composition. Alternatively, if xylitol is used as a sweetener, it may be present at a lower level, such as from 0.005% to 5%, by weight of the dentifrice composition.
Surfactant levels cited herein are on a 100% active basis, even though common raw materials such as sodium lauryl sulphate may be supplied as aqueous solutions of lower activity. The surfactant is important for oral cleaning, both thorough removal of dirt from surfaces and in foam generation to suspend removed dirt. Suitable surfactant levels are from about 2% to about 15%, preferably from about 2.2% to about 10%, more preferably from about 2.5 to about 5% by weight of the total composition. Suitable surfactants for use herein include anionic, amphoteric, non-ionic, zwitterionic and cationic surfactants, though anionic, amphoteric, non-ionic and zwitterionic surfactants (and mixtures thereof) are preferred.
An abrasive is normally included in the composition. Abrasives may be selected from water-insoluble alkali or alkaline earth metal salts of metaphosphate, calcium carbonate, aluminate and silicate. Especially preferred are
silica, dicalcium phosphate and calcium carbonate. Amount of the abrasive range from about 5 to about 80% by weight of the composition. Also suitable are chalk-type abrasives such as calcium and magnesium carbonates, silicas including xerogels, hydrogels, aerogels and precipitates, alumina and hydrates thereof.
Abrasives include alpha alumina trihydrate, aluminosilicates such as calcined aluminium silicate and aluminium silicate, magnesium and zirconium silicates such as magnesium trisilicate and thermosetting polymerised resins such as particulate condensation products of urea and formaldehyde, polymethylmethacrylate, powdered polyethylene. Mixtures of abrasives can also be used.
The abrasive polishing materials generally have an average particle size of from about 0.1 to about 30 microns, preferably from about 5 to 15 microns.
Silica dental abrasives of various types offer exceptional dental cleaning and polishing performance without unduly abrading tooth enamel or dentin. The silica abrasive can be precipitated silica or silica gels for example silica xerogels marketed under the trade name SYLOID® by W. R. Grace & Company, Davison Chemical Division. Suitable precipitated silica materials include those marketed by the J. M. Huber Corporation under the trade name, ZEODENT® 119 or ZEODENT® 118. Suitable abrasive levels are from about 1% to about 40%, preferably at least about 2%, such as from about 2% to about 20%, more preferably at least about 5%, such as from about 5% to about 15% by weight of the composition.
Tartar control agents may be incorporated into compositions of this invention, especially effective are agents containing phosphorous. Inorganic phosphorous tartar control agents may include any of the water-soluble pyrophosphates such as disodium pyrophosphate, dipotassium pyrophosphate and mixtures of these with tetrapotassium pyrophosphates or tetrasodium pyrophosphates.
Organic phosphorous compounds that may serve as tartar control agents include polyphosphonates such as disodium ethane-l-hydroxy-1, 1-diphosphonate (EHDP) and methanediphosphonic acid.
Typically compositions according to the invention have a pH in the range of 5 to 8, preferably 6.5 to 7.5, e.g. 7.
The present invention also relates to a process for making a dentifrice composition that includes mixing 0.1 to 5 parts by weight zinc salt with 0.01 to 1 parts by weight polyethylene oxide having molecular weight of from 100,000 to 8,000,000 g/mol and 10 to 70 parts by weight humectant, with a suitable vehicle.
To prepare a dentifrice composition of the present invention, one may add the humectants, such as glycerine and sorbitol, the high molecular polyethylene oxide for use according to the invention, and the zinc salt to water and mix for 10 to 15 minutes in a conventional mixer. Thereafter, optional ingredients, e.g. silica and carboxymethylcellulose, may be added and mixing continued
for a further 10 to 15 minutes, followed by addition of surfactants. The mix may then be de-aerated under vacuum. Flavour and colour ingredients may then be added and mixing continued for a further 10-15 minutes and further de- aeratation under vacuum. The resultant product is typically a stable dentifrice of texture like that of normal gels and of satisfactory flavour.
The invention will now be explained in greater details with the help of the following non-limiting examples.
Example 1
A core and sheath type of toothpaste was made with the core and the sheath being a gel. The ingredients of the composition (Composition -1) have been listed in table-1.
Similarly, placebo toothpaste (gel) was made, which had all ingredients except for zinc sulphate. The balance was made up by adding little extra water.
Table- 1
Performance of Composition-1 and the placebo toothpaste was compared.
Organoleptic studies
190 volunteers in the age group of 18-45 (both male and female) in good health participated in the organoleptic odour study. All volunteers were stratified by age, gender and baseline scores. The volunteers had at least 24 teeth, of which at least 20 teeth had no disease of teeth or gums. They were asked to avoid antibiotics for 3 weeks before test
and were asked to refrain from oral activities ( brushing, gargling, rinsing, eating , drinking , chewing gum, smoking) at least two hours before testing. Volunteers abstained from eating spicy food for 24 hours prior to each visit and refrained from consuming alcohol for 24 hours before each visit .
Four trained organoleptic judges participated in scoring the volunteers. These judges were also asked to refrain from drinking hot beverages, smoking, consuming alcohol or using cosmetics during the study. Each volunteer was asked to close the mouth for 60 seconds and not swallow during this period. After one minute the volunteer breathed out the mouth air gently through a diameter of 24mm / length 5 cm tube at a distance of approximately 10 cm from the nose of the odour judge who were hidden behind the screen and would immediately record the odour on a 0-5 organoleptic scale.
The organoleptic scale of 0 to 5 was as follows: 0 No odour present
1 Barely noticeable odour. Odour is of low intensity and within organoleptically acceptable limits.
2 Slight to moderate odour. Odour is clearly noticeable and slightly unpleasant. 3 Moderate to high malodour. Clearly noticeable, unpleasant malodour of moderate intensity
4 Strong malodour of high intensity
5 Extremely foul odour
All volunteers were asked to refrain from brushing 12 hours prior to the baseline reading. Only those volunteers with
breath score of 3 or > 3 were selected for the study. After the baseline score, they were made to brush their teeth with one full brush length of toothpaste for 3 minutes, followed by rinsing with 25 ml of water. Each volunteer was asked to refrain from drinking and eating till the end of evaluation. The volunteers were scored by at least two judges at all the time points: before brushing (12 hrs post brushing), 10 minutes after brushing and 2 hours after brushing. All analysis was carried out with the student's t-test to derive the significance at 95% confidence level.
The results are summarised in table-2 below.
Table-2
''Comp-l is Composition-1 ,
Thus it will be seen that Composition-1 offers a significant reduction in oral malodour level on day-1 itself, even after two hours of brushing.
Further, the Composition-1 offers significant reduction in malodour level even before brushing (i.e. after 12 hours from the last brushing, overnight) on 4 weeks of continued use (twice daily) and the difference between the placebo score and that of composition-1 after 2 hours of brushing in this case is very significant. This therefore, goes to
- I i
indicate that the composition is capable of offering protection against oral malodour for a significantly longer period of time upon continued usage.
Halimeter Studies
Further, the above results were also verified by analysing the Volatile Sulphur Content (VSC) in the breath of the volunteers, as this is a direct and more reliable method of analysis. The breath of the volunteers were analysed by using an instrument called a halimeter, which detects and shows the VSC levels in ppb (parts per billion) .
In this case, the tests were also done after 2 and 4 weeks of continued use for which 188 volunteers in the age group of 18-45 (both male and female) participated.
All volunteers were stratified on the basis of age, gender and baseline score being a controlled parallel group design study. All volunteers with a VSC score >120 ppb and < 250 ppb were included in the study.
They were asked to avoid antibiotics for 3 weeks before test and were asked to refrain from oral activities ( brushing, gargling, rinsing, eating , drinking , chewing gum, smoking) at least two hours before testing. Volunteers abstained from eating spicy foods for 24 hours prior to each visit.
They also refrained from consuming alcohol for 24 hours before each visit. Oral malodour measurements (an average of 3 readings) were made on each volunteer using the Halimeter. On the morning of each test, the volunteers did not consume any food/confectionery or use any mouthwash prior to their baseline assessment. Volunteers abstained from eating and
drinking for the duration of each visit. After the baseline assessment, volunteers were made to brush one full brush length with the appropriate dentifrice for 2 minutes. Oral malodour measurements were made using the InterScan Halimeter Model RH-17K (standard Operating Procedure) at 12 hours before brushing, 10 minutes after brushing and 2 hours post brushing.
The baseline reading for both the product groups were matched. The analysis was carried out with the "student's t- test" to obtain the significance at 95% confidence level. The above protocol of short term design was followed after 4 weeks of product use, and measurements on the halimeter were taken at 12 hours before brushing, 10 minutes after brushing and 2 hours post brushing for both the control toothpaste and Composition-1.
The results of before brushing and 2 hours post-brushing are summarised in table-3 below.
Table-3
cComp-l is Composition-1
Thus it can be seen that the composition-1 according to the invention, reduces VSC levels significantly, and more so, after continued use for 2 and 4 weeks.
In addition to the above experiments, the volunteers who had used the individual compositions for a period of 4 weeks, self-assessed the composition-1 and placebo for their comparative Freshness values after use and rated the same on a scale of 0 to 5, 0 being the lowest and 5 being the best after the end of the period. The results are summarised in table-4 below.
Table-4
*Comp-l is Composition-1.
The results indicate that the freshness score for the composition-1 was higher as compared to that for the placebo, especially after brushing, and after 2 hours of brushing .
Example 2
In another set of experiments, compositions containing 0.2, 0.4 and 0.7% zinc sulphate were made in which the formulations were identical to that in Table-1, except for the increased/decreased levels of zinc Sulphate, with a corresponding increase/decrease in the content of water in the corresponding formulations.
Efficacy of the dentifrices was evaluated by studying BDCOH (4 , 4 ' -bis (dimethylamino) diphenylcarbinol) levels in saliva, pre and post brushing. This is also an indicator of the level of malodour.
Study of BDCOH levels in breath
In-vivo protocol Approximately 2 ml saliva samples were collected in an autoclaved plastic vial from 50 volunteers (each) before brushing and before eating anything in the morning. The samples were diluted to different level of dilutions and BDCOH solution was added in the vial. A micro titre plate was read at 620 nm in SpectraMax plate reader and the concentration of salivary thiols was calculated. This is inversely proportional to concentration of salivary thiols.
Ex-vivo protocol 35 volunteers produced un-stimulated saliva samples after brushing with placebo and Composition-1 at zero-time, 30 minutes post-brush and 2 hrs post-brush. The samples were assayed for concentration of salivary thiols after 24 hours of incubation using BDCOH. The micro titre plate was read at 620 nm in SpectraMax Plate reader and the concentration of salivary thiols was calculated.
Higher the concentration of BDCOH, lower the concentration of salivary thiols in the incubated saliva samples.
Results (BDCOH values) are compiled in table-5 below.
Table-5
Values in the above table indicate that the BDCOH levels showed an increase after brushing, to a significant extent, especially for compositions containing 0.2 to 0.7% Zinc Sulphate. This indicates that the inventive compositions are able to prevent the formation of malodour causing salivary thiols to a significant extent, even after 2 hours of brushing .
In addition to providing benefits against malodour, the compositions according to the invention also provide other desirable consumer benefits.
The following composition, Comparative Example 1, was prepared and was used by 200 volunteers for a period of 1 week, twice daily. Thereafter, they rated the composition for various consumer desirable benefits, as being on parity or better than the composition according to the invention as in table-1.
The composition of Comparative Example-1 was prepared was as per the formulation in table-6 below.
Table- 6
Comparative ratings given by the volunteers for the compositions have been summarised in the table-7 below.
Table- 7
The data in table-7 indicates that the volunteers preferred Composition 1 over Comparative Example 1 for most of the important attributes.
The above table indicates that Composition 1 (in accordance with the invention) is able to meet most of the desirable consumer attributes, when compared to a formulation devoid of high molecular weight polyethylene oxide in accordance.
In addition, Composition-1 and Comparative Example-1 were also compared by 15 expert panel members. The aim of this study was to evaluate and compare the mouth feel, foam levels, flavour intensity and flavour related attributes.
Panellists brushed their teeth with one full brush length for 60 seconds. They assessed the various attributes using the line scale from 0 to 10, zero being the lowest and 10 being the highest score. Average results of their comparative assessment have been compiled in the following table-8.
Table-8
From the scores in table-8 (in particular the relative astringency scores) as well as from the data in table-7 above, it is clear that Composition-1, in accordance with the invention has much lower astringency score when compared to the astringency of Comparative Example-1.
It will be appreciated that the illustrated examples, provides for a dentifrice composition including zinc salts, while having relatively lower astringency.
It will also be appreciated that the illustrated examples, provides for a dentifrice composition which gives enhanced level of breath freshness, particularly overnight breath freshness .
Although the invention has been described with reference to specific embodiments, it will be appreciated by those
skilled in the art that the invention may be embodied in many other forms .
Claims
1. A dentifrice composition comprising i. 0.1 to 5 % by weight zinc salt; ii . 0.01 to 1.0 % by weight polyethylene oxide having a molecular weight between 100,000 and 8,000,000 g/mol; and iii. 10 to 70 % by weight humectant.
2. A dentifrice composition as claimed in claim 1 comprising 0.1 to 2 % by weight zinc salt.
3. A dentifrice composition as claimed in claim 2 comprising 0.1 to 0.5 % by weight zinc salt.
4. A dentifrice composition as claimed in any one of the preceding claims comprising 0.1 to 0.5 % by weight of said polyethylene oxide.
5. A dentifrice composition as claimed in any one of the preceding claims wherein said zinc salt is selected from zinc chloride, zinc sulphate or zinc citrate.
6. A dentifrice composition as claimed in claim 5 wherein said zinc salt is zinc sulphate.
7. A dentifrice composition as claimed in any one of the preceding claims wherein the molecular weight of said polyethylene oxide is from 600,000 to 2,000,000 g/mol,
8. A dentifrice composition as claimed in claim 7 wherein the molecular weight of said polyethylene oxide is from 800,000 to 1,000,000 g/mol.
9. A dentifrice composition as claimed in any one of the preceding claims wherein said humectant comprises glycerine and sorbitol.
10. A dentifrice composition as claimed in any one of the preceding claims wherein said composition comprises a flavour .
11. A process for making a dentifrice according to any one of the preceding claims comprising mixing 0.1 to 5 parts by weight zinc salt; 0.01 to 1.0 parts by weight polyethylene oxide having molecular weight between 100,000 to 8,000,000 g/mol and 10 to 70 parts by weight humectant with water.
12. The use of a dentifrice as claimed in any one of the preceding claims 1 to 10 as a medicament.
13. The use of 0.1 to 5 % by weight zinc salt; 0.01 to 1.0
% by weight polyethylene oxide having a molecular weight between 100,000 and 8,000,000 g/mol; and 10 to 70 % by weight humectant in the manufacture of a dentifrice composition for use to improve the condition of teeth and/or improve breath freshness.
14. A dentifrice composition substantially as herein described with reference to the accompanying examples.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08774508A EP2167021A1 (en) | 2007-07-16 | 2008-06-30 | Dentrifice composition |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1356MU2007 | 2007-07-16 | ||
| EP07119468 | 2007-10-29 | ||
| EP08774508A EP2167021A1 (en) | 2007-07-16 | 2008-06-30 | Dentrifice composition |
| PCT/EP2008/058354 WO2009010381A1 (en) | 2007-07-16 | 2008-06-30 | Dentrifice composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP2167021A1 true EP2167021A1 (en) | 2010-03-31 |
Family
ID=39651426
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP08774508A Withdrawn EP2167021A1 (en) | 2007-07-16 | 2008-06-30 | Dentrifice composition |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP2167021A1 (en) |
| CN (1) | CN101801336A (en) |
| WO (1) | WO2009010381A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2201910B1 (en) | 2007-06-01 | 2013-04-03 | Allergan, Inc. | Biological tissue growth support trough induced tensile stress |
| EP3595626B1 (en) * | 2017-03-13 | 2021-10-13 | Unilever IP Holdings B.V. | Oral care compositions |
| BR112022017654A2 (en) * | 2020-03-03 | 2022-10-18 | Unilever Ip Holdings B V | AQUEOUS TOOTHPASTE GEL WITHOUT ALCOHOL |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3888976A (en) * | 1972-09-21 | 1975-06-10 | William P Mlkvy | Zinc and strontium ion containing effervescent mouthwash tablet |
| US4416867A (en) * | 1979-06-20 | 1983-11-22 | Lever Brothers Company | Oral compositions |
| JPH0747531B2 (en) * | 1986-06-27 | 1995-05-24 | ライオン株式会社 | Oral composition |
| NZ232572A (en) * | 1989-03-13 | 1991-11-26 | Vipont Pharma | Oral rinse composition containing a benzophenanthridine alkaloid extract from sanguinaria canadesis |
| US5302373A (en) * | 1993-06-10 | 1994-04-12 | Church & Dwight Co., Inc. | Liquid mouthwash containing a particulate bicarbonate suspension |
| US5820854A (en) * | 1997-03-27 | 1998-10-13 | The Procter & Gamble Company | Oral compositions containing polyoxyethylene |
| US5820853A (en) * | 1997-03-27 | 1998-10-13 | The Procter & Gamble Company | Oral compositions forming a coacervate gel |
-
2008
- 2008-06-30 WO PCT/EP2008/058354 patent/WO2009010381A1/en not_active Ceased
- 2008-06-30 EP EP08774508A patent/EP2167021A1/en not_active Withdrawn
- 2008-06-30 CN CN200880107283A patent/CN101801336A/en active Pending
Non-Patent Citations (1)
| Title |
|---|
| See references of WO2009010381A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101801336A (en) | 2010-08-11 |
| WO2009010381A1 (en) | 2009-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5695746A (en) | Liquid dentifrice with mouthwash fresh taste | |
| AU615746B2 (en) | Oral compositions | |
| CA2728391C (en) | Composition and method for enhancing fluoride uptake using bioactive glass | |
| US11351193B2 (en) | Compositions and methods for dental mineralization | |
| CN1373652A (en) | Oral composition containing tea polyphenols | |
| US5064640A (en) | Anticariogenic compositions | |
| CA2026292A1 (en) | Plaque disclosing compositions | |
| US4935226A (en) | Toothpastes | |
| KR20070064661A (en) | Taste-enhanced zinc-containing toothpaste composition | |
| Parnell et al. | After-brush rinsing protocols, frequency of toothpaste use: fluoride and other active ingredients | |
| WO2001082922A1 (en) | Oral compositions comprising polyphenol herbal extracts | |
| US20100047191A1 (en) | Novel use | |
| US9314411B2 (en) | Silica abrasive-free dentifrice composition | |
| JP2000154127A (en) | Oral composition | |
| JPS6011412A (en) | Oral cavity sanitary composition and manufacture | |
| US4663154A (en) | Oral compositions | |
| EP1183006B1 (en) | Oral composition containing perlite | |
| WO2009010381A1 (en) | Dentrifice composition | |
| AU598324B2 (en) | Anticariogenic compositions | |
| US4959204A (en) | Oral compositions | |
| KR100807079B1 (en) | Toothpaste composition containing plant leaf slices | |
| Mason | Dental hygiene | |
| JP3821553B2 (en) | Liquid dentifrice | |
| NZ214807A (en) | Dentifrice or mouthwash containing hydrogen citrate ions and fluoride ions | |
| US9205036B2 (en) | Dental composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20100108 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR |
|
| AX | Request for extension of the european patent |
Extension state: AL BA MK RS |
|
| 17Q | First examination report despatched |
Effective date: 20100812 |
|
| DAX | Request for extension of the european patent (deleted) | ||
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20101223 |